Related Experiment Video
Updated: Nov 6, 2025

08:55
Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
Published on: April 24, 2020
3.3K
Intraocular Pressure Variations After Intravitreal Injections Measured With an Implanted Suprachoroidal Telemetry
Enrico Meduri1, Kevin Gillmann1, Kaweh Mansouri1,2
1Glaucoma Research Center, Montchoisi Clinic, Swiss Visio, Lausanne, Switzerland.
Journal of Glaucoma
|May 12, 2021
Summary
Intravitreal injections can cause temporary intraocular pressure (IOP) changes. Initially, they may lower IOP, but later can cause sharp spikes, indicating healing and fibrosis after surgery.
Area of Science:
- Ophthalmology
- Biomedical Engineering
Background:
- Intravitreal injections (IVIs) are common treatments for various ocular conditions.
- Transient intraocular pressure (IOP) elevation is a known risk associated with IVIs.
- Monitoring continuous IOP fluctuations post-IVIs is crucial for patient management.
Observation:
- A suprachoroidal tonometry sensor was implanted in a patient with glaucoma and macular edema undergoing deep sclerectomy.
- Continuous IOP was monitored before and after serial IVIs over a 1-year period.
- The sensor enabled real-time tracking of IOP dynamics following each injection.
Findings:
- In the initial 7 months post-surgery, IVIs led to a transient reduction in IOP, attributed to subconjunctival leaks or increased filtration.
- From 7 months onward, IVIs caused significant IOP spikes, with one reaching 44.8 mm Hg, suggesting resolution of initial leakage mechanisms.
- IOP normalized within hours post-injection in both phases, but the pattern shifted from reduction to sharp increase.
Implications:
- The study highlights the dynamic and evolving nature of IOP response to IVIs after deep sclerectomy.
- Understanding these IOP fluctuations is vital for optimizing treatment strategies and preventing complications in patients with glaucoma and macular edema.
- Implantable IOP sensors offer valuable insights into the physiological responses to intravitreal therapies.
Related Concept Videos
Glaucoma: Overview
1.0K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.0K
Open Angle Glaucoma: Treatment
783
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
783

